NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMS+) Q1 2024 Earnings

May 6Expected
Q1 2023
Q2 2023
Q3 2023
Q1 2024
-1.01
-0.67
-0.34
0

Details

Expected EPS
-0.6147
Actual EPS
0
Surprise EPS
0.61
Surprise Percent
+100%

Description

⁨NewAmsterdam Pharma Company NV - Warrants (15/11/2027)⁩ (⁦NAMS+⁩) has reported earnings of ⁦0⁩ per share for ⁦Q1 2024⁩.

0 Comments

Share your thoughts